# FDA Inspection 957571 - Novo Nordisk A/S - 25a-B - January 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-25a-b/a97b3042-eb3e-405d-901c-868c1f2c0ae4
Source feed: FDA_Inspections

> FDA inspection 957571 of Novo Nordisk A/S - 25a-B, January 22, 2016. Classification: Voluntary Action Indicated (VAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 957571
- Company Name: Novo Nordisk A/S - 25a-B
- Inspection Date: 2016-01-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1223821 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-25a-b/1311c640-239f-42db-a99a-a4b693406f50)
- FDA Inspection 1207487 - 2022-11-04
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 933969 - 2015-06-18
- FDA Inspection 909374 - 2014-10-10

Company: https://www.keypedia.com/companies/novo-nordisk-as-25a-b/017e6784-9871-4c62-9884-314e60ba61b7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d